|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
IMMUNOBIOLOGY
From the Department of Internal Medicine (the Viral
Hepatitis and AIDS Study Group) and Department of Radiology, Hospital
Universitario Virgen del Rocío, Seville, Spain.
The origin of T cells after highly active antiretroviral therapy
(HAART) in patients infected with human immunodeficiency virus 1 (HIV-1) is now under discussion. The possibility of renewed lymphopoiesis in aged thymuses is still controversial. In this work we
combine the analysis of naïve T cells, T-cell receptor excision
circles (TRECs), and computed tomography scanning of thymic tissue to
further assess whether the thymus is involved in immune reconstitution.
Fifteen antiretroviral-naïve HIV-1-infected patients were
evaluated during 48 weeks of HAART. At baseline, significant
correlation was present among age and both thymic volume and TRECs, and
between naïve T cells and TRECs. After starting HAART, there
was a significant increase at week 12 in naïve CD4+
and CD8+ T cells, TRECs, and thymic volume. The initial net
increases in naïve T cells and TREC counts were significantly
correlated. Changes in thymic volume and TRECs were also indirectly
related; splitting the population into 2 groups of high and low
baseline TREC levels, only the group with low TREC levels had
significant increases in both TRECs and thymic volume. Thus, the
increase in thymic volume might be functional, in response to depleted TREC levels. Taken together, our data strongly suggest a thymic role in
immune reconstitution, at least in patients with depleted baseline TREC levels.
(Blood. 2002;99:3702-3706) Infection by human immunodeficiency virus 1 (HIV-1)
is characterized by a progressive depletion of not only naïve
and memory CD4+ T-cell subsets, but also the naïve
subset of CD8+ T cells.1,2 These alterations
can be partially corrected after inhibition of HIV-1 replication by
highly active antiretroviral therapy (HAART), although the mechanism
for which T-cell counts increase thereafter is still controversial. In
fact, more than one mechanism might be involved. Soon after starting
HAART, a rapid increase in peripheral blood CD4+ T-cell
counts probably reflects a redistribution from lymph node-sequestered memory T cells,3,4 which ends after a few weeks. On the
other hand, naïve CD4+ and CD8+ T-cell
increases are slower but maintained for a longer
period.5
An especially interesting issue is whether the thymus contributes to
the repopulation of naïve T cells or whether they are derived
from other sources. In the setting of pediatric HIV-1 infection,
naïve T-cell repopulation after antiretroviral treatment is
early6 and correlated with enlarged thymic
volumes.7 However, the thymic role in immune
reconstitution of adults remains a controversial issue, due to the
accepted thymic involution in adulthood. Thymic evaluation by computed
tomography (CT) scans has shown a higher initial increase in
naïve T-cell counts in patients with abundant thymic tissue
after 48 weeks of HAART.8 However, early increases in
naïve T cells after starting HAART have been also reported in
some thymectomized HIV-1-infected patients.9 In addition,
the determination of thymic output by quantification of T-cell receptor
excision circles (TRECs) has been recently described. TRECs are
byproducts of T-cell receptor (TCR) gene rearrangements,
generated during lymphocyte maturation in the thymus.10,11
They are stable, not duplicated during mitosis, and rapidly diluted in
proliferating T-cell subpopulations. It has been shown that TREC levels
are increased after HAART in adult patients,10,11
suggesting a renewed thymic function. However, the decrease in T-cell
turnover after HAART12,13 may be an alternative
explanation for the TREC levels increases.
Thus, the objective of this work was to further study whether immune
reconstitution after HAART includes the generation of recent thymic
emigrants (RTEs). In this way, we have combined the quantification of
thymic volumes (by CT), TREC levels, and naïve T cells, in
HIV-1-infected patients following 48 weeks of HAART.
Patients
CT
Flow cytometry Cells were thawed and an aliquot assessed for percentages of naïve T-cell subsets (CD4+CD45RA+CD45RO and
CD8+CD45RA+CD11alow) as previously
described.6 Absolute counts were calculated by multiplying
their representation in frozen samples by the absolute CD4+
and CD8+ T-cell subset counts obtained from fresh
blood samples.
Quantification of TREC levels in PBMCs One proposed molecular marker for determination of RTEs are the TRECs generated during thymocyte maturation. A polymerase chain reaction (PCR)-based method for quantifying Rec- J TRECs has
been described by Douek et al.10 We have adapted this PCR to a real-time PCR setting, using a LightCycler (Roche Molecular Biochemicals, Mannheim, Germany), for quantification of both the characteristic signal-joint sequences harbored by TRECs and genomic  -globin gene sequences (to normalize by DNA content).
The TREC levels in each PBMC sample were determined using an external standard curve made with DNA from a unique pediatric thymic sample for the entire study. A postnatal thymus sample was obtained during corrective cardiac surgery of an HIV-uninfected 2-year-old patient, after approbation by the Ethical Committee of the hospital. A single-cell suspension of thymocytes was obtained by mechanical disruption and Fycoll-Hypaque centrifugation. Previously, the 376-base pair amplification product of the signal-joint sequence was obtained from that thymic sample using PCR conditions described below, and cloned into the pGEM T-EASY vector (Promega, Madison, WI). Identity of the cloned PCR product was confirmed by sequencing. Using known concentrations of the cloned fragment, the number of TREC molecules in the reference thymic sample was calculated as 62 500 TREC/106 cells. All follow-up samples from each individual were simultaneously measured in duplicate PCR reactions. All samples available were PCR positives for TRECs, with a distribution between 100 and 11 000 TREC/ 106 PBMCs. In addition to the TREC/106 PBMCs, the absolute counts of TREC/µL were derived for each sample. Because all the TRECs in PBMCs are included inside the CD3+ subpopulation,11 the TREC/106 PBMC proportion was corrected by the percentage of CD3+ cells found by flow cytometry in the PBMCs, yielding the number of TREC/106 CD3+ cells. This proportion was then multiplied by absolute CD3+ cell counts obtained in fresh blood by flow cytometry. The amplified signal-joint TREC fragment was detected by fluorescence resonance energy transfer between 2 adjacent hybridization probes. Jurkat E6-1 DNA was used as a negative control. PCR reactions were performed in a volume of 20 µL, with 400 nmol/L of each primer (5'-AAA GAG GGC AGC CCT CTC CAA GGC, 5'-AGG CTG ATC TTG TCT GAC ATT TGC TCC G), 100 nmol/L of each detection probe (5'-AGG GAT GTG GCA TCA CCT TTG TTG ACA labeled on its 3' end with fluorescein, 5'-GGC ACC CCT CTG TTC CCC ACA GGA, labeled with the acceptor fluorophore LightCycler RED 640 at its 5' end), and 100 to 400 ng DNA. LightCycler DNA Master Hybridization Probes buffer was used (Roche Molecular Biochemicals) with a final Mg++ concentration of 3.5 mM. After an initial denaturation step at 95°C for 120 seconds, amplification was performed by 45 cycles of denaturation (95°C for 0 seconds), annealing (63°C for 40 seconds), and extension (72°C for 40 seconds). To normalize by genomic DNA concentration, primers GH20 and PC04 for
the human Quantification of HIV-1 RNA Plasma HIV-1 RNA copies were measured by a quantitative PCR (HIV Monitor Test kit version 1.5, Roche Molecular System, Hoffman-La Roche, Basel, Switzerland) according to the manufacturer's instructions. This assay has a detection limit of 50 HIV-1 RNA copies/mL.Statistical analysis Results are expressed as mean ± SEM. The Spearman correlation coefficient analysis was used to assess the correlation between variables. The Wilcoxon signed rank test was used to compare follow-up values versus baseline and the Mann-Whitney U test was used for differences among groups of patients. Statistical analyses were performed using the SPSS software package (Statistical Package for the Social Sciences 8.0, Chicago, IL).
Characteristics of the patients at baseline Fifteen patients were included in the study. The mean age of the patients was 33.5 years (range, 25-60 years), and 3 of them were women. Mean CD4+ T-cell count was 347 cells/µL (range, 8-804 cells/µL; 4 patients had fewer than 200 CD4+ T cells/µL). The mean plasma HIV-1 RNA level was 4.1 log10 copies/mL (range, 3.0-5.6 log10 copies/mL).At baseline, the thymic function-related markers were significantly
interrelated. Figure 1A shows the inverse
correlation between age and thymic volume. Note that patients with high
thymic tissue scores were also younger. TREC/106 PBMC
values were inversely correlated with age (Figure 1B) and directly
correlated with thymic volume (Figure 1C). TREC levels were very low
among the 3 patients with acquired immunodeficiency syndrome (between
140 and 333 TREC/106 PBMCs). Finally, a significant
correlation was present between the number of TRECs and both the
naïve CD4+ (R = 0.696,
P = .004) and naïve CD8+ T-cell counts
(R = 0.568, P = .027) at baseline.
Naïve T-cell counts were then combined, and Figure 1D shows the
significant relationship between the total naïve T-cells count
(CD4+ plus CD8+) and TREC counts.
Patients' response to HAART The mean change from baseline in plasma HIV-1 RNA at week 12 was 2.53 log10 copies/mL. From week 12 to the end of
follow-up, viral load levels were generally below 50 copies/mL.
CD4+ T-cell counts were increased from 347 ± 66 cells/µL to 489 ± 73 cells/µL at week 48. The
CD4+ T-cell increase versus baseline was significant from
week 12 of treatment (Wilcoxon signed rank test,
P = .005). There were no significant changes in mean
CD8+ T-cell counts during the follow-up period.
Changes in thymic function-related markers after HAART For kinetics studies, TRECs were expressed as absolute counts per microliter rather than a proportion in PBMCs. After starting HAART, there was a significant increase in naïve CD4+ T cells/µL, naïve CD8+ T cells/µL, TREC/µL, and thymic volumes for the overall population (Figure 2). All these thymic function-related markers were already significantly increased versus baseline within 12 weeks (Wilcoxon signed rank test, P < .05). Thymic scores of radiographic density were not significantly changed between baseline and the whole study period (data not shown).
The analysis of these simultaneous increases showed a direct
relationship between early changes in naïve T cells and TRECs. The change at week 12 (versus baseline) in TREC counts was
significantly correlated with changes in both the naïve
CD4+ (R = 0.582, P = .029,
Spearman test) and the naïve CD8+ T-cell counts
(R = 0.582, P = .029). Figure
3 shows the correlation between changes
in TRECs and the combined CD4+ plus CD8+
naïve T-cell counts. No more significant correlation was
present at 24, 36, or 48 weeks between changes in TRECs and
naïve T cells.
Something that caught our attention was the more evident increase in TREC counts after HAART in patients with low baseline TREC levels. Thus, our 15 patients were split into 2 groups, according to the baseline median TREC count (2.92 TREC/µL), for further analysis. Patients with TREC counts at baseline below the median were designated group 1 (n = 7), and patients above or equal to the median were designated group 2 (n = 8). There was no significant difference in age (Mann-Whitney U test, P = .104) between the groups. Baseline CD4+ T-cell counts were significantly lower in group 1 (208 ± 89 cells/µL) than in group 2 (469 ± 75 cells/µL, Mann-Whitney U test, P = .049). After starting HAART, only the group 1 patients had significant
increases in TREC/µL counts versus baseline (Figure
4A, Wilcoxon signed rank test,
P < .05). Thus, no more significant differences in TREC
counts were present between the groups at weeks 36 and 48 (Mann Whitney
U test). In the same way, the slopes of the regression line
fitting the patients' TREC/µL counts during follow-up were higher
for group 1 (+4.85 × 10
At baseline, no significant differences between the groups were found for thymic volumes (Mann-Whitney U test, P = .908). However, thymic volumes were significantly increased after HAART in group 1 (Figure 4B) but not in group 2. In this way, thymic volume was significantly higher in group 1 than in group 2 at week 12 (P = .013), week 24 (P = .006), and very near to statistical significance at week 48 (P = .057). Naïve CD4+ and CD8+ T-cell counts were significantly lower in group 1 (47.9 ± 20.9 cells/µL and 60.5 ± 15.1 cells/µL, respectively) than in group 2 (146.4 ± 25.8 cells/µL and 125.7 ± 22.4 cells/µL, respectively) at baseline (Mann-Whitney U test, P = .015 and P = .037, for naïve CD4+ and CD8+ T-cell counts, respectively). After HAART, CD4+ plus CD8+naïve T-cell counts were increased in both groups, and no more significant differences were present between them at any treatment point. The increases in total naïve T-cell counts were significant versus baseline from week 12 for group 1 (Figure 4C, Wilcoxon signed rank test, P < .05), and were very near to statistical significance for group 2 (Wilcoxon signed rank test, P = .050 at weeks 12 and 24 versus baseline).
To study the role of the thymus during immune reconstitution in HIV-1-infected adult patients, we have analyzed changes in naïve T cells, TREC levels, and thymic volume in a group of antiretroviral naïve patients receiving 48 weeks of HAART. The main finding of this study was the significant increase in both TREC levels and thymic volumes after starting HAART. These increases were particularly evident among the patients with low TREC counts at baseline. As far as we know, this is the first study to combine thymic imaging, TREC levels, and naïve T-cell analysis to analyze thymic functionality. Taken together, our data strongly suggest the possibility of a new production of RTE after inhibition of HIV-1 replication, in a functional response of the thymus to a state of low TREC levels. It has been previously demonstrated that HAART induces an increase in the proportion of TRECs in both PBMCs and sorted CD4+ or CD8+ T cells from HIV-1-infected patients.10,11 This fact has been related to enhanced thymic function after HAART because the only known pathway for TREC production in humans is thymocyte differentiation. However, the proportion of TRECs in naïve T cells is the result of a complex equilibrium between thymic output, cell death, and cell proliferation. In this way, it has been shown that cell proliferation is the leading force depleting TREC levels after HIV-1 infection.17 Thus, TREC increases have been also related to the concomitant reduction in T-cell proliferation and activation after HAART.12,13 In this work, we have found significant increases in both proportions (data not shown) and absolute TREC counts after HAART. This increase in absolute number needs an active output of TRECs to peripheral blood, rather than a simple reduction in T-cell division rates or the elimination of TREC-negative, activated T cells (which can alter TREC proportions). Although we cannot exclude a redistribution of lymph node-sequestered naïve T cells as the source for TREC influx in peripheral blood, a simultaneous increase in thymic volume should suggest that new TRECs are being generated and exported as RTE cells by the thymus. In this work, we also show a significant increase in patients' thymic volumes after starting HAART. The possibility of increasing thymic tissue in the setting of HIV-1 infection had been previously suggested by CT scans in antiretroviral-naïve, HIV-1-infected adults.15 However, common limitations of thymic imaging techniques are the true delimitation of thymic and mediastinal fat tissues and the inability to differentiate between active thymopoiesis and lymphocytic infiltration.18 Thus, other thymic function markers should be additionally addressed when assessing renewed lymphopoiesis in aged thymus. In this way, the relationships between thymic volume and thymic function have been supported by the described significant association between changes in thymic volume and number of CD4+ naïve T cells after HAART in children.7 In adults, this relationship has been hampered by the absence of reports assessing thymic size dynamic after HAART, although a relationship between amount of thymic tissue after 48 weeks of HAART and the early changes in naïve T cells has been shown.8 As far as we know, the thymic measurement technique used in this work has not previously been used in other HIV-1-infected patients. Our detailed delineation of thymic shadows along several thin sections allowed us to accurately determine the thymic volume, minimizing possible inclusion of mediastinal fat. Moreover, we have found relations between TREC levels and thymic volume; at baseline, a direct relation between TREC/106 PBMCs and thymic volume was present. In addition, we have found that when the patients were divided into 2 groups with low or high baseline TREC counts, only the group with low TRECs had significant increases in both TRECs and thymic volumes. Taken together, these simultaneous increases in TREC levels and thymic volumes after HAART may be easily interpreted as a functional increase in thymic volume, in response to depleted TREC levels, suggesting a real production of RTEs after HAART. Another key issue in the evaluation of thymic involvement in the increase in naïve T-cell subsets after HAART is the quantification of thymopoiesis versus peripheral expansion of mature T cells. In healthy individuals, naïve T cells are resting cells, switching to a memory phenotype when activated to proliferate.19 In HIV-1 infection, however, an increased rate in T-cell proliferation is shown for all T-cell subsets, including naïve T cells.12,20 A homeostatic peripheral expansion of naïve T cells seems to be possible in HIV-1 infection, being an alternative source of naïve T cells. Peripheral expansion of naïve T cells will be in agreement with the significantly lower TREC proportion per naïve T cells in HIV-1-infected versus uninfected subjects, with the exponential relationship between remaining TREC and naïve T-cell counts previous to HAART shown in this work, with the reported higher increase in naïve than in TREC counts after HAART11 (and this work), and with the lack of correlation between changes in TREC and naïve T-cell counts after 24, 36, or 48 weeks of HAART (this work). To assess how many naïve T cells are from thymic origin, an important issue is to extrapolate RTE production from TREC increases. The number of TRECs per RTEs is unknown, although it should be similar to children's peripheral blood and cord blood T cells (approximately 1 TREC for each 10-20 naïve T cells,10,11,21 and data not shown). According to these values, the patients with the lower TREC counts at baseline, who had evidence of thymic reactivation after HAART, showed a significant increase at week 12 of +1.5 TREC/µL (equivalent to 15-30 RTE/µL). This suggests that RTEs might be the 10% to 20% of the naïve T-cell increase (+155 naïve T cells/µL). At week 24, the net increases were 2.76 TREC/µL and 121 naïve T cells/µL (20%-40%). These data suggest that thymic function seems to be recuperated early after control of viral replication, although additional pathways of naïve T-cell repopulation are also present, such as the peripheral expansion of RTEs or mature preexisting naïve T cells. In conclusion, in this work we have found evidence supporting a functional increase in thymic size after HAART, engaged in an early generation of new RTEs in adult patients. The generation of RTEs was more evident in patients showing depleted TREC levels prior to antiretroviral therapy.
We would like to thank the individuals who participated in this study, as well as M. Olivera and A. Gayoso for excellent technical assistance.
Submitted September 20, 2001; accepted January 8, 2002.
Supported by research grants from "Fondo de Investigaciones Sanitarias" (FIS 00/0521), Fondo para la Investigación y Prevención del SIDA en España (FIPSE 2132/00, integrated by Ministerio de Sanidad y Consumo, Abbott Laboratories, Boehringer Ingelgeim, Bristol Myers Squibb, GlaxoSmithKline, Merck Sharp and Dohme, and Roche), and by the kindly support of Fundación Wellcome España.
The publication costs of this article were defrayed in part by page charge payment. Therefore, and solely to indicate this fact, this article is hereby marked "advertisement" in accordance with 18 U.S.C. section 1734.
Reprints: Manuel Leal, Department Medicina Interna, Hospital U. Virgen del Rocío, CP 41013, Av Manuel Siurot s/n, Seville, Spain; e-mail: mleal{at}cica.es.
1. Connors M, Kovacs J-A, Krevat S, et al. HIV infection induces changes in CD4+ T-cell phenotype and depletions within the CD4+ T-cell repertoire that are not immediately restored by antiviral or immune-based therapies. Nat Med. 1997;3:533-540[CrossRef][Medline] [Order article via Infotrieve]. 2. Roederer M, Dubs J-G, Anderson M-T, Raju P-A, Herzenberg L-A. CD8 naïve T cell counts decrease progressively in HIV-infected adults. J Clin Invest. 1995;95:2061-2066. 3. Bucy R-P, Hockett R-D, Derdeyn C-A, et al. Initial increase in blood CD4+ lymphocytes after HIV antiretroviral therapy reflects redistribution from lymphoid tissues. J Clin Invest. 1999;103:1391-1398[Medline] [Order article via Infotrieve]. 4. Pakker N-G, Notermans D-W, de Boer R-J, et al. Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: a composite of redistribution and proliferation. Nat Med. 1998;4:208-214[CrossRef][Medline] [Order article via Infotrieve].
5.
Autran B, Carcelain G, Li T-S.
Positive effects of combined antiretroviral therapy on CD4+ T-cell homeostasis and function in advanced HIV disease.
Science.
1997;277:112-116 6. Franco J-M, León-Leal J-A, Leal M, et al. CD4+ and CD8+ T lymphocytes regeneration after anti-retroviral therapy in HIV-1-infected children and adult patients. Clin Exp Immunol. 2000;119:493-498[CrossRef][Medline] [Order article via Infotrieve]. 7. Vigano A, Vella S, Saresella M, et al. Early immune reconstitution after potent antiretroviral therapy in HIV-infected children correlates with the increase in thymus volume. AIDS. 2000;14:251-261[CrossRef][Medline] [Order article via Infotrieve]. 8. Smith K-Y, Valdez H, Landay A, et al. Thymic size and lymphocyte restoration in patients with human immunodeficiency virus infection after 48 weeks of zidovudine, lamivudine, and ritonavir therapy. J Infect Dis. 2000;181:141-147[CrossRef][Medline] [Order article via Infotrieve]. 9. Haynes B-F, Hale L-P, Weinhold K-J, et al. Analysis of the adult thymus in reconstitution of T lymphocytes in HIV-1 infection. J Clin Invest. 1999;103:453-460[Medline] [Order article via Infotrieve]. 10. Douek D-C, McFarland R-D, Keiser P-H, et al. Changes in thymic function with age and during the treatment of HIV infection. Nature. 1998;396:690-695[CrossRef][Medline] [Order article via Infotrieve].
11.
Zhang L, Lewin S-R, Markowitz M, et al.
Measuring recent thymic emigrants in blood of normal and HIV-1-infected individuals before and after effective therapy.
J Exp Med.
1999;190:725-732
12.
Lempicki R-A, Kovacs J-A, Baseler M-W, et al.
Impact of HIV-1 infection and highly active antiretroviral therapy on the kinetics of CD4+ and CD8+ T cell turnover in HIV-infected patients.
Proc Natl Acad Sci U S A.
2000;97:13778-13783 13. Gea-Banacloche J-C, Clifford Lane H. Immune reconstitution in HIV infection. AIDS. 1999;13(suppl A):S25-S38.
14.
Choyke P-L, Zeman R-K, Gootenberg J-E, Greenberg J-N, Hoffer F, Frank J-A.
Thymic atrophy and regrowth in response to chemotherapy: CT evaluation.
Am J Roentgenol.
1987;149:269-272 15. McCune J-M, Loftus R, Schmidt D-K, et al. High prevalence of thymic tissue in adults with human immunodeficiency virus-1 infection. J Clin Invest. 1998;101:2301-2308[Medline] [Order article via Infotrieve]. 16. Bauer H-M, Ting Y, Greer C-E, et al. Genital human papillomavirus infection in female university students as determined by a PCR-based method. JAMA. 1991;265:472-477[Abstract]. 17. Hazenberg M-D, Otto S-A, Cohen Stuart J-W-T, et al. Increased cell division but not thymic dysfunction rapidly affects the T-cell receptor excision circle content of Th naïve T cell population in HIV-1 infection. Nat Med. 2000;6:1036-1042[CrossRef][Medline] [Order article via Infotrieve]. 18. Haynes B-F, Hale L-P. The human thymus. A chimeric organ comprised of central and peripheral lymphoid components. Immunol Res. 1998;18:175-192[Medline] [Order article via Infotrieve].
19.
Mackall C-L, Fleisher T-A, Brown M-R, et al.
Age, thymopoiesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy.
N Engl J Med.
1995;332:143-149
20.
Hazenberg M-D, Stuart J-W, Otto S-A, et al.
T-cell division in human immunodeficiency virus (HIV)-1 infection is mainly due to immune activation: a longitudinal analysis in patients before and during highly active antiretroviral therapy (HAART).
Blood.
2000;95:249-255
21.
Patel D-D, Gooding M-E, Parrott R-E, Curtis K-M, Haynes B-F, Buckley R-H.
Thymic function after hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency.
N Engl J Med.
2000;342:1325-1332
© 2002 by The American Society of Hematology.
| ||||||||||||||||||||||
 |
|
 |
|
  M.-L. Dion, R. Bordi, J. Zeidan, R. Asaad, M.-R. Boulassel, J.-P. Routy, M. M. Lederman, R.-P. Sekaly, and R. Cheynier Slow disease progression and robust therapy-mediated CD4+ T-cell recovery are associated with efficient thymopoiesis during HIV-1 infection Blood, April 1, 2007; 109(7): 2912 - 2920. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Di Mascio, I. Sereti, L. T. Matthews, V. Natarajan, J. Adelsberger, R. Lempicki, C. Yoder, E. Jones, C. Chow, J. A. Metcalf, et al. Naive T-Cell Dynamics in Human Immunodeficiency Virus Type 1 Infection: Effects of Highly Active Antiretroviral Therapy Provide Insights into the Mechanisms of Naive T-Cell Depletion J. Virol., March 15, 2006; 80(6): 2665 - 2674. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Grabar, L. Weiss, and D. Costagliola HIV infection in older patients in the HAART era J. Antimicrob. Chemother., January 1, 2006; 57(1): 4 - 7. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K.-i. Yamanaka, N. Yawalkar, D. A. Jones, D. Hurwitz, K. Ferenczi, S. Eapen, and T. S. Kupper Decreased T-Cell Receptor Excision Circles in Cutaneous T-Cell Lymphoma Clin. Cancer Res., August 15, 2005; 11(16): 5748 - 5755. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Chakraborty, A.-S. Morel, J. K. Sutton, V. Appay, R. M. Ripley, T. Dong, T. Rostron, S. Ogola, T. Palakudy, R. Musoke, et al. Correlates of Delayed Disease Progression in HIV-1-Infected Kenyan Children J. Immunol., June 15, 2005; 174(12): 8191 - 8199. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Thiebot, B. Vaslin, S. Derdouch, J.-M. Bertho, F. Mouthon, S. Prost, G. Gras, P. Ducouret, D. Dormont, and R. Le Grand Impact of bone marrow hematopoiesis failure on T-cell generation during pathogenic simian immunodeficiency virus infection in macaques Blood, March 15, 2005; 105(6): 2403 - 2409. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. de la Rosa and M. Leal Thymic involvement in recovery of immunity among HIV-infected adults on highly active antiretroviral therapy J. Antimicrob. Chemother., August 1, 2003; 52(2): 155 - 158. [Full Text] [PDF]
|
|
|
|
 |
|
 T. Pham, M. Belzer, J. A. Church, C. Kitchen, C. M. Wilson, S. D. Douglas, Y. Geng, M. Silva, R. M. Mitchell, and P. Krogstad Assessment of Thymic Activity in Human Immunodeficiency Virus-Negative and -Positive Adolescents by Real-Time PCR Quantitation of T-Cell Receptor Rearrangement Excision Circles Clin. Vaccine Immunol., March 1, 2003; 10(2): 323 - 328. [Abstract] [Full Text] [PDF]
|
|
| |||||||||||||||||||||||
Top
Abstract
Introduction
corresponds to the differences in naïve T-cell counts and
of TREC/µL between baseline and week 12 of HAART. Correlation was
tested by the Spearman test. No significant correlations were present
in the differences between baseline and week 24, 36, or 48.
